We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
AUM
$1.51B
AUM Growth
+$414M
Cap. Flow
-$406M
Cap. Flow %
-26.85%
Top 10 Hldgs %
44.89%
Holding
542
New
183
Increased
53
Reduced
33
Closed
94

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.92%
2 Financials 15.61%
3 Technology 1.32%
4 Real Estate 1.26%
5 Industrials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PALO
201
Paloma Acquisition Corp I
PALO
$991K 0.07%
+100,000
New +$989K
CTAA
202
ClearThink 1 Acquisition Corp
CTAA
$170M
$991K 0.07%
+100,000
New +$988K
CMPS
203
PUT
Compass Pathways
CMPS
$1.9B
$991K 0.07%
70,000
+1,800
+3% +$18.3K
ILLU
204
Illumination Acquisition Corp I
ILLU
$312M
$990K 0.07%
+100,000
New +$989K
APUR
205
Aperture AC
APUR
$147M
$990K 0.07%
+100,000
New +$990K
KPTI icon
206
PUT
Karyopharm Therapeutics
KPTI
$42.4M
$990K 0.07%
+101,500
New +$880K
SUMA
207
SUMA Acquisition Corp
SUMA
$232M
$989K 0.07%
+100,000
New +$985K
RREV
208
RRE Ventures Acquisition Corp
RREV
$331M
$987K 0.07%
+100,000
New +$988K
NVO
209
CALL
Novo Nordisk
NVO
$202B
$959K 0.06%
+20,000
New +$859K
NVO
210
PUT
Novo Nordisk
NVO
$202B
$959K 0.06%
+20,000
New +$859K
XRXDW
211
Xerox Holdings Corp Warrants
XRXDW
$22.7M
$872K 0.06%
3,170,000
+763,383
+32% +$208K
CYTK icon
212
CALL
Cytokinetics
CYTK
$10B
$852K 0.06%
10,000
+2,500
+33% +$180K
FACT
213
FACT II Acquisition Corp
FACT
$260M
$817K 0.05%
+76,830
New +$815K
TII
214
CALL
Titan Mining Corp
TII
$303M
$789K 0.05%
+357,000
New +$889K
KPTI icon
215
CALL
Karyopharm Therapeutics
KPTI
$42.4M
$781K 0.05%
+80,100
New +$695K
CEPS
216
Cantor Equity Partners VI
CEPS
$153M
$764K 0.05%
73,676
+10,565
+17% +$108K
IPXG
217
Inflection Point Acquisition Corp. VII Class A Ordinary Shares
IPXG
$315M
$761K 0.05%
75,000
SAC
218
Safeguard Acquisition Corp
SAC
$317M
$758K 0.05%
75,300
MESH
219
Meshflow Acquisition Corp
MESH
$435M
$751K 0.05%
75,000
PAAC
220
Proem Acquisition Corp I
PAAC
$177M
$746K 0.05%
+75,000
New +$743K
KOPN icon
221
CALL
Kopin
KOPN
$833M
$731K 0.05%
+163,600
New +$713K
JAZZ icon
222
PUT
Jazz Pharmaceuticals
JAZZ
$15.9B
$723K 0.05%
+3,000
New +$657K
DFTX
223
PUT
Definium Therapeutics
DFTX
$5.51B
$710K 0.05%
+15,100
New +$373K
HMC icon
224
Honda
HMC
$41.3B
$706K 0.05%
+26,029
New +$662K
DFTX
225
CALL
Definium Therapeutics
DFTX
$5.51B
$705K 0.05%
+15,000
New +$371K

Similar funds

DLD Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, DLD Asset Management held 542 positions worth $1.51B, up 38% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

DLD Asset Management withdrew a net $406M in Q2 2026, closing 94 positions and reducing 33 holdings. Its most notable exit was Medline Inc, an estimated $9.79M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, DLD Asset Management opened a new position in Amkor Technology worth $12.1M.

  • DLD Asset Management's largest Q2 2026 buy was Amkor Technology: 140,000 shares worth $12.1M.
  • DLD Asset Management added most to Norfolk Southern in Q2 2026, an estimated $4.48M increase.
  • DLD Asset Management's biggest Q2 2026 reduction was D. Boral Acquisition I Corp, cutting an estimated $4.96M.
  • DLD Asset Management fully exited Medline Inc in Q2 2026, selling an estimated $9.79M.
  • DLD Asset Management's ten largest holdings make up 45% of its $1.51B portfolio in Q2 2026.
  • DLD Asset Management opened 183 new positions and closed 94 in Q2 2026.
  • DLD Asset Management's portfolio value rose 38% quarter-over-quarter to $1.51B.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.